NEOGENOMICS INC — Director's Dealing 2018

May 10, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2018-05-01

Reporting Person: BYWATER STEPHANIE K (Chief Compliance Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	528	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Common Stock	$7.72	2022-05-15	Common Stock (50000.0)		Direct
Common Stock	$8.03	2023-02-26	Common Stock (24000.0)		Direct

Footnotes

F1: On May 15, 2017, Ms. Bywater was granted options to purchase shares of NeoGenomics, Inc. common stock. The options vest ratably over the first three anniversary dates of the grant date.

F2: On February 26, 2018, Ms. Bywater was granted options to purchase shares of NeoGenomics, Inc. common stock. The options vest ratably over the first three anniversary dates of the grant date.